# Bravecto Quantum for Dogs: Dosage and Safety

Bravecto Quantum is an injectable fluralaner suspension for dogs. A veterinarian gives one subcutaneous injection at 15 mg/kg, and the formulation is designed to provide flea and tick control for 12 months [1][2][3]. It is not a chewable tablet, a spot-on, a heartworm preventive, or an intestinal dewormer. It is a long-acting ectoparasiticide for dogs that meet the product label and have a year-round flea and tick risk.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

## At a Glance

| Feature | Bravecto Quantum injectable suspension |
|--|--|
| Active ingredient | Fluralaner, 150 mg/ml injectable suspension |
| Species | Dogs only |
| Label age and weight | The dog must meet the product label's minimum age and weight, confirmed by the veterinarian |
| How it is given | Subcutaneous injection by a veterinarian, at 0.1 mL/kg body weight, which delivers 15 mg/kg fluralaner |
| How fast it works | Kills fleas and ticks after they attach and feed. It is not an instant repellent |
| How long it lasts | 12 months from a single injection in the cited studies |
| Prescription status | Veterinary-administered prescription product |

## What Bravecto Quantum Is and Who It Is For

Bravecto Quantum is a long-acting injectable formulation of fluralaner. Fluralaner belongs to the isoxazoline class, a group of parasiticides with potent insecticidal and acaricidal activity [4][5]. The injectable suspension is supplied as a powder and solvent that a veterinary clinic prepares for subcutaneous injection [3]. The dose is calculated from the dog's body weight, and the injection is given in the clinic rather than at home.

The product was developed for year-round flea and tick control when repeated owner-administered treatments are unreliable [1][2]. A single injection removes the need for 12 monthly doses or four 12-week doses in the year. That can matter for dogs whose owners travel, work unpredictable hours, or simply forget repeated treatments.

Bravecto Quantum is not the same as the Bravecto chewable tablet or the Bravecto topical solution. Oral and topical fluralaner products for dogs are labeled for [12-week redosing](/knowledge/veterinary-medicine/calculators-clinical-tools/bravecto-dose-guide-fluralaner-12-week-flea-tick-dose) [4][6][7]. The injectable suspension is a separate formulation with a 12-month duration in the studies described here [1][2][3]. In the United States, [Bravecto products for dogs](/knowledge/veterinary-medicine/clinical-methods/bravecto-for-dogs) are widely known as oral chews and a topical solution with 12-week redosing [4][6][7]. Owners should ask their veterinarian whether the injectable suspension is approved and available where they live.

## How Fluralaner Works

<!-- art-pending: scripts/editorial-illustration/specs/bravecto-quantum-fluralaner-molecule.json -->

Fluralaner is an isoxazoline that acts on neuronal chloride channels, with selectivity for invertebrate parasites over mammals [5]. In practical terms, it interferes with nerve signaling in fleas and ticks, which leads to paralysis and death after the parasite attaches and feeds.

Fluralaner is systemically distributed. A dog treated with fluralaner has drug present in tissues and blood, so fleas and ticks are exposed when they take a blood meal rather than by walking across a treated coat [8]. This is why the product can kill ticks that attach after the injection. The tick does not need to ingest a large amount of drug. Oral fluralaner studies showed that tick killing begins after attachment and that only marginal uptake is needed for efficacy [8]. The injectable suspension maintains fluralaner exposure long enough to provide persistent activity across 12 months [1][3].

This mechanism also explains the product's limits. Bravecto Quantum is not a tick repellent that stops every tick from landing on the dog. It is not a rapid environmental flea spray. It is an systemic parasiticide that kills fleas and ticks after exposure. Owners should still check the dog for ticks, especially after walks in wooded or grassy areas.

## Dosage and Administration

### The labeled dose

![Calculation that a 20 kg dog gets 2 mL of the 150 mg/ml suspension, which delivers 15 mg/kg fluralaner.](/article-images/illustrations/bravecto-quantum-dose-volume-calc.webp)

The dose in the clinical studies was 15 mg/kg fluralaner, given once subcutaneously on day 0 [1][2][9][3]. The injectable suspension contains 150 mg/ml, so the administered volume is 0.1 mL/kg body weight [3]. A 10 kg dog would receive 1 mL by that calculation. A 20 kg dog would receive 2 mL. The veterinarian calculates the exact volume from the dog's current weight.

The injection is subcutaneous, not intramuscular or intravenous [3]. The product is prepared by the clinic from powder and solvent, then given as a single injection. Owners should not attempt to buy, mix, or inject this product at home.

### What owners should expect at the appointment

The veterinarian will weigh the dog, review its health history, and confirm that it meets the label's age and weight requirements. The dog's weight on the day of injection matters because the dose is weight-based. Tell the veterinarian if the dog has gained or lost weight since the last visit.

The injection itself is brief. The dog does not need anesthesia for a routine subcutaneous injection. The clinic may ask owners to stay for a short observation period, especially if the dog has had reactions to injections or medications before. Ask the veterinarian what signs to watch for during the first 24 to 48 hours.

### Redosing and missed doses

The studies describe a single injection providing protection for 12 months [1][2][3]. The next dose is therefore due at the 12-month point, unless the veterinarian recommends a different schedule for the individual dog. Do not shorten the interval without veterinary advice. Do not give a second injection at home.

If the yearly appointment is missed, contact the clinic promptly. A late injection can leave a gap in protection. The right response is not to double the dose or add a different isoxazoline without veterinary direction. The veterinarian will assess the dog's risk, check for live fleas or ticks, and decide when to restart or switch products.

### What owners should not do

Do not use Bravecto Quantum in cats. Do not use it in dogs below the label's minimum age or weight. Do not split the dose, give it orally, or apply it topically. Do not combine it with another isoxazoline flea and tick product unless the veterinarian specifically directs that plan.

## What It Covers and What It Does Not

Bravecto Quantum is labeled for flea and tick control in dogs. The injectable formulation has been studied against repeated infestations with *Rhipicephalus sanguineus* sensu lato, the brown dog tick, and *Ctenocephalides felis*, the cat flea [1][3]. It has also been studied against *Ixodes holocyclus*, the paralysis tick [9].

The product is not a heartworm preventive. It is not a broad intestinal dewormer. It does not replace vaccination, fecal testing, or other routine care. Flea control can reduce the risk of *Dipylidium caninum* transmission because that tapeworm depends on fleas for part of its lifecycle, and fluralaner treatment prevented tapeworm transmission in a flea-infestation study [10]. That does not make Bravecto Quantum a [tapeworm treatment](/knowledge/veterinary-medicine/pet-medication-guide/drontal-dogs-dosage-chart). A dog with tapeworm segments in the stool needs a specific deworming plan.

The product also does not treat tick-borne infections. The field study measured live ticks and fleas, not disease outcomes [2]. A dog with fever, lameness, lethargy, pale gums, bruising, or other signs of illness needs veterinary testing even if it has received Bravecto Quantum. Tick control reduces exposure, but it does not guarantee that an attached tick has not transmitted a pathogen before it dies.

## How Fast It Works and How Long It Lasts

Bravecto Quantum is not an instant knockdown product. Fleas and ticks are killed after they attach and feed. In a study of *Ixodes holocyclus*, efficacy against existing infestations was 64.1% at 72 hours after treatment [9]. That number describes one tick species in one study. It does not mean every existing tick is gone within three days, and it does not mean the dog is free of ticks for the rest of the year without routine checks.

The main advantage of the injectable formulation is duration. In laboratory studies, a single subcutaneous injection at 15 mg/kg provided persistent efficacy against repeated tick and flea challenges across 12 months [1][3]. In a European field study, a single fluralaner injection was compared with 12 monthly oral afoxolaner treatments in household dogs over one year [2]. The injectable formulation was developed to remove the need for multiple owner-administered treatments within the year [2].

Owners should think of Bravecto Quantum as a year-long background control product. It reduces flea and tick populations on the dog. It does not make the dog sterile to parasites. A dog can still pick up a tick on a walk. The tick should be removed promptly, and the dog should be checked for signs of tick-borne illness.

## Safety Profile

### What controlled studies show

The injectable fluralaner suspension was well tolerated in the controlled studies that supported its use. In a 12-month laboratory study with repeated tick and flea infestations, the formulation was well tolerated [1]. The *Ixodes holocyclus* studies also used a single 15 mg/kg injection and monitored dogs for tolerability [9]. The European field study observed all treated dogs for adverse reactions throughout the year [2].

These studies are the best direct evidence for the injectable product. They enrolled dogs that met the study criteria and were monitored by veterinarians. They do not prove that a product is risk-free for every dog. They do show that serious tolerability problems were not a prominent feature of the controlled injectable research.

### Neurological signs and class safety

Isoxazolines as a class have been associated with [rare neurological adverse events](/knowledge/veterinary-medicine/pet-medication-guide/bravecto-side-effects-dogs). A case report described a seven-month-old Kooikerhondje that developed generalized ataxia, myoclonic jerks, head and body tremor, muscle twitching, and oral dysphagia about 24 hours after oral Bravecto at the recommended dose. The signs were transient, and the dog recovered without treatment within 10 hours [5]. That report involved the oral chew, not the injectable suspension, and a single case cannot establish a risk rate for either product.

A large owner survey of isoxazoline use reported neurological and other adverse events after flea and tick treatment [11]. The [survey design](/blog/guides/survey-design-for-qualitative-research-best-practices) cannot prove that the parasiticide caused every reported sign, and it did not establish an incidence rate for the injectable product. The findings are still relevant to owners because they show why neurological signs after any isoxazoline deserve prompt veterinary attention. The authors also noted that reported serious adverse events were higher in some post-marketing datasets than in pre-approval submissions, and that isoxazoline neurotoxicity was not flea- and tick-specific [11].

For Bravecto Quantum, the practical message is simple. Tell the veterinarian about any history of seizures, tremors, wobbliness, or other neurological signs before the injection. Report any new neurological sign afterward at once. Do not wait for the next scheduled visit.

### Injection-site and general reactions

Because Bravecto Quantum is an injection, the injection site deserves attention. Report swelling, pain, redness, warmth, or discharge at the site. Report vomiting, diarrhea, lethargy, loss of appetite, or a change in behavior after treatment. These signs are not necessarily caused by the product, but they need veterinary assessment.

Severe allergic signs are rare but urgent. Facial swelling, hives, difficulty breathing, collapse, or repeated vomiting require emergency care. A dog that cannot stand, has a seizure, or shows severe tremors should be seen immediately.

### What to do if a reaction occurs

![Decision path sorting mild injection-site or stomach signs from severe allergic or neurological signs after Bravecto Quantum.](/article-images/illustrations/bravecto-quantum-reaction-triage.webp)

Call the veterinarian who gave the injection. Describe the signs, the time they started, and any other medicines the dog received. Do not give another dose of any flea and tick product until the veterinarian has reviewed the case. For severe signs, go to an emergency clinic rather than waiting for a callback.

Ask the veterinarian to document the event. Suspected adverse events should be reported through the veterinarian's usual pharmacovigilance process so that the manufacturer and regulators can track patterns.

## Who Should Not Receive It

Bravecto Quantum is for dogs only. Do not use it in cats. Do not use it in dogs below the product label's minimum age or weight. Do not use it in a dog with a known hypersensitivity to fluralaner or to any component of the formulation.

Dogs with a history of seizures or neurological disease need an individual risk discussion before any isoxazoline. The case report of transient neurological signs after oral fluralaner is a reason for caution, not a reason to assume every dog will react [5]. The veterinarian should weigh the dog's parasite risk against the uncertain risk of neurological signs.

Use in pregnant, breeding, or lactating dogs requires veterinary risk assessment. The controlled injectable studies reviewed here were not designed to establish safety in those groups. The same applies to dogs with serious liver, kidney, or other systemic disease. Stabilize the dog's health first, then decide on parasite control.

## Interactions and Concurrent Care

Fluralaner is systemically distributed, so its activity depends on drug exposure inside the dog [8]. Tell the veterinarian about every medicine, supplement, and topical product the dog receives. That includes heartworm preventives, intestinal dewormers, antibiotics, anti-inflammatory drugs, seizure medications, and other flea and tick products.

Do not combine Bravecto Quantum with another isoxazoline unless the veterinarian directs it. Do not add a flea collar, spot-on, or oral flea product with the same or similar active ingredient without checking the label and the veterinary plan. The goal is to avoid duplicate exposure and to keep the parasite-control plan coherent.

Heartworm prevention and intestinal parasite control remain separate decisions. Bravecto Quantum does not replace a heartworm test, a heartworm preventive, or fecal testing. A dog that travels to heartworm-endemic areas needs a prevention plan tailored to that risk.

## Comparison With Other Flea and Tick Products

![Comparison of Bravecto Quantum injection, oral fluralaner chew, topical fluralaner and monthly oral afoxolaner by route and redosing.](/article-images/illustrations/bravecto-quantum-product-route-compare.webp)

| Product type | Route | Typical redosing in the cited studies | Main practical difference |
|--|--|--|--|
| Bravecto Quantum injectable | Subcutaneous injection by a veterinarian | Once every 12 months | Removes owner-administered doses for a year, requires a clinic visit |
| Oral fluralaner chew | By mouth | Every 12 weeks | Owner gives a chew at home, shorter interval than the injectable |
| Topical fluralaner | Applied to the skin | Every 12 weeks | Owner applies at home, shorter interval than the injectable |
| Oral afoxolaner | By mouth | Monthly | Monthly owner dosing, used as the comparator in a one-year field study |
| Topical fipronil | Applied to the skin | Monthly | Monthly owner dosing, used as a comparator in earlier flea and tick field work |

Oral fluralaner chews and topical fluralaner are labeled for 12-week redosing in dogs [4][6][7]. They are effective options for owners who can manage four treatments per year. The injectable suspension is different because a single clinic visit covers 12 months [1][2][3].

In a European field study, a single fluralaner injection was non-inferior to 12 monthly oral afoxolaner treatments for keeping primary dogs free of live ticks or fleas at the final visit [2]. That does not mean the injectable is superior to monthly afoxolaner. It means the injectable performed comparably in that study population while requiring one treatment instead of 12.

The choice between products depends on the dog and the household. An injectable product reduces the chance of missed doses. It also means the owner cannot stop the product at home if a reaction occurs, and it requires a veterinary visit for administration. A chew or topical product gives the owner more control over when to stop, but it depends on repeated owner action. Dogs with a history of neurological signs need a specific conversation about isoxazoline risk regardless of the route.

## Owner Adherence and Year-Round Protection

Flea and tick control fails when the product is not given as directed. Studies of owner purchasing patterns show that longer intervals can improve the number of protected months. In Spain, owners who obtained a 12-week fluralaner product took home an average of 4.3 months of protection, compared with 3.24 months for monthly oral products and 2.9 months for monthly spot-on products [12]. In the United States, the pattern was similar, with 5.7 months for fluralaner, 4.6 months for afoxolaner, and 3.3 months for spinosad [13]. Many owners still obtained only one dose per year [12][13].

A US survey found that almost all veterinary hospitals recommended 12 months of flea and tick prevention, but only 62% of owners recalled that recommendation, and the average owner believed 10.5 months of prevention was needed annually [14]. Owner surveys also show that longer intervals are preferred by many clients who use fluralaner [15].

These findings support the rationale for a 12-month injectable. One clinic-administered dose removes the daily or monthly decision from the owner. The trade-off is that the owner must schedule the yearly visit and bring the dog in on time. Bravecto Quantum does not solve non-compliance by itself. It shifts the compliance point from repeated home dosing to one annual appointment.

## Questions to Ask Your Veterinarian

- Does my dog meet the label's minimum age and weight for Bravecto Quantum?
- Is the injectable suspension approved and available in this country or state?
- Which fleas and ticks in my area are covered by this product?
- Does my dog's health history, including any seizures or neurological signs, change the risk-benefit balance?
- What should I do if I find a live tick after the injection?
- When exactly is the next dose due, and how should I handle a late injection?
- Should my other pets receive a different flea and tick product?
- How do I report a suspected adverse event?

## Limitations and When to Contact a Veterinarian

Bravecto Quantum is a long-acting product, so a reaction cannot be removed by bathing the dog or stopping a daily pill. That makes pre-treatment screening and post-treatment monitoring important. Every dog needs an individual assessment by a veterinarian.

Contact the veterinarian promptly for mild signs such as vomiting, diarrhea, reduced appetite, lethargy, or a painful or swollen injection site. Contact the veterinarian immediately for facial swelling, hives, difficulty breathing, collapse, repeated vomiting, severe lethargy, tremors, wobbliness, seizures, or a dog that cannot stand.

Contact the veterinarian if live fleas or ticks persist despite treatment, if the dog develops fever, lameness, pale gums, bruising, weight loss, or other signs of illness, or if the yearly injection is overdue. Do not wait for a scheduled recheck when a dog is unwell.

## Household and Yard Flea Control After the Injection

Bravecto Quantum protects the dog, not the home. Fluralaner is distributed systemically, so fleas and ticks are exposed only when they feed on the treated dog [8]. The drug does not spread into carpets, bedding, or yard soil, and it does not kill flea eggs, larvae, or pupae in the environment. A home with an active flea infestation can keep producing new adult fleas for weeks after the injection.

### Why the environment still matters

Adult fleas on the dog lay eggs that fall into carpets, upholstery, bedding, and floor cracks. These immature stages are not exposed to fluralaner. They develop into adults over days to weeks, then jump onto the dog and die after feeding. Seeing fleas in the home during the first weeks after treatment is therefore expected, not a sign that the injection failed.

### Practical steps

- Vacuum carpets, rugs, upholstery, and floor cracks daily for at least two weeks. Empty the vacuum outdoors.
- Wash the dog's bedding and any fabric the dog sleeps on in hot water weekly.
- Keep grass short and remove leaf litter in areas where the dog rests or plays.
- Use a yard product labeled for fleas only if the dog spends time there, and follow the label exactly.
- Do not use foggers or sprays without checking that they are safe for all pets in the home.

### Other pets and persistent fleas

The injection protects only the treated dog. Every other dog and cat in the household needs its own veterinary-approved [parasite control plan](/knowledge/veterinary-medicine/dermatology-oncology/demodectic-mange-vs-sarcoptic-mange-diagnosis-mite-scrapes-and-bravecto). [Bravecto Quantum is not for cats](/knowledge/veterinary-medicine/pet-medication-guide/bravecto-for-cats-dosage-safety-and-side-effects). If fleas are still present in large numbers after several weeks, or if the dog continues to pick up fleas indoors, contact the clinic. Persistent household fleas usually mean the environment needs targeted treatment and all pets need a coordinated plan.

## Finding a Live Tick or Flea on a Treated Dog

A live tick or flea after Bravecto Quantum is not proof that the injection failed. Fluralaner is not a repellent. Fleas and ticks are killed after they attach and feed, so a parasite found early may still be alive [8]. A flea seen soon after treatment may also be newly acquired from the environment. The injection is designed to provide 12 months of control [1][2][3], but it does not make the dog parasite-proof.

### Removing a tick safely

- Use fine-tipped tweezers.
- Grasp the tick as close to the skin as possible.
- Pull upward with steady pressure. Do not twist or jerk.
- Clean the bite area with soap and water or a disinfectant.
- Save the tick in a sealed container and note the date. Do not crush it with bare fingers.

### Do not re-dose

Do not give another flea or tick product, and do not shorten the yearly interval, without veterinary advice. The intended redosing point is 12 months. An extra dose will not remove an attached tick faster and adds unnecessary drug exposure.

### When to call the veterinarian

Contact the clinic if live ticks persist, if fleas remain visible, or if the dog becomes unwell after a tick bite. Signs of tick-borne illness include fever, lethargy, lameness, swollen joints, pale gums, bruising, weight loss, or neurological signs. These need veterinary testing even when prevention is current.

Seek urgent care for difficulty breathing, collapse, seizures, severe tremors, repeated vomiting, widespread bruising or bleeding, or a dog that cannot stand. Bring the saved tick if you have one.

## Travel, Boarding, and Moving With a Dog on Bravecto Quantum

A single injection covers 12 months, which simplifies travel planning, but it does not remove the need for documentation and a pre-trip veterinary check [1][2][3].

### Proof of injection and veterinary records

Carry a written treatment record from the clinic. It should show the product name, the injection date, the dog's weight, and the veterinarian's signature or clinic stamp. Boarding facilities, dog shows, and some border crossings may ask for proof of parasite treatment alongside rabies vaccination. Ask the clinic for a printed record before you travel, and keep a photo copy on your phone as a backup.

### Product availability and legality elsewhere

Bravecto Quantum is not approved in every country. Confirm with your veterinarian and with the destination's veterinary authority that the injectable product is legal and available where you are going. If the dog needs a booster or a switch to another product while away, the local clinic may not stock the injectable. Carry the product name and the active ingredient, fluralaner, in writing so a foreign veterinarian can identify it.

### Timing the annual dose around trips

If the dog is due for its yearly injection, schedule it at least a few days before departure. This allows time to observe for injection-site reactions or other signs while you are still at home. If the trip falls near the 12-month mark, give the injection before travel rather than after, to avoid a gap in protection. For example, a dog injected on 1 March 2026 is due on 1 March 2027. A trip planned for 20 February 2027 means the injection should be given before departure, with veterinary approval.

### Planning parasite prevention before travel or relocation

A new region may expose the dog to different fleas, ticks, or vector-borne diseases. Bravecto Quantum covers fleas and ticks, but not heartworm or intestinal parasites. Before travel or relocation, book a veterinary visit to review regional risks and to add preventives if needed. Do not assume the injection covers every parasite in the new area.

## Related Guides

- [How Long Does Bravecto for Cats Last? The 3-Month Answer](/knowledge/veterinary-medicine/pet-medication-guide/bravecto-for-cats-how-long-last): Explains duration of Bravecto in cats, useful for multi-pet homes
- [Quantum Mechanical / Molecular Mechanical Modeling of Enzyme Catalysis](/knowledge/bioinformatics/quantum-mechanical-molecular-mechanical-modeling-of-enzyme-catalysis)
- [The Future of Quantum Computing in Bioinformatics](/knowledge/bioinformatics/the-future-of-quantum-computing-in-bioinformatics)

## Frequently Asked Questions

### What is Bravecto Quantum?

Bravecto Quantum is an injectable fluralaner suspension for dogs that provides flea and tick control from a single subcutaneous dose.

### How is Bravecto Quantum given to dogs?

A veterinarian gives it as a subcutaneous injection at 15 mg/kg, which is 0.1 mL/kg of the 150 mg/ml suspension.

### How long does one Bravecto Quantum injection last?

One injection is designed to provide 12 months of flea and tick control in the cited studies.

### Does Bravecto Quantum kill ticks and fleas immediately?

No. It kills fleas and ticks after they attach and feed, so it is not an instant repellent.

### Can Bravecto Quantum be used in puppies or small dogs?

Only if the dog meets the product label's minimum age and weight and a veterinarian approves it.

### What are the serious side effects of Bravecto Quantum?

Rare neurological signs have been reported with isoxazolines, including a case after oral fluralaner. Report tremors, wobbliness, seizures, or behavior change at once.

### Can I give my dog oral or topical flea medicine with Bravecto Quantum?

Ask your veterinarian first. Do not combine another isoxazoline without specific veterinary direction.

### What should I do if my dog misses the yearly injection?

Contact your veterinarian promptly. A late injection can create a gap in protection.

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is Bravecto Quantum?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Bravecto Quantum is an injectable fluralaner suspension for dogs that provides flea and tick control from a single subcutaneous dose."
      }
    },
    {
      "@type": "Question",
      "name": "How is Bravecto Quantum given to dogs?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A veterinarian gives it as a subcutaneous injection at 15 mg/kg, which is 0.1 mL/kg of the 150 mg/ml suspension."
      }
    },
    {
      "@type": "Question",
      "name": "How long does one Bravecto Quantum injection last?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "One injection is designed to provide 12 months of flea and tick control in the cited studies."
      }
    },
    {
      "@type": "Question",
      "name": "Does Bravecto Quantum kill ticks and fleas immediately?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No. It kills fleas and ticks after they attach and feed, so it is not an instant repellent."
      }
    },
    {
      "@type": "Question",
      "name": "Can Bravecto Quantum be used in puppies or small dogs?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Only if the dog meets the product label's minimum age and weight and a veterinarian approves it."
      }
    },
    {
      "@type": "Question",
      "name": "What are the serious side effects of Bravecto Quantum?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Rare neurological signs have been reported with isoxazolines, including a case after oral fluralaner. Report tremors, wobbliness, seizures, or behavior change at once."
      }
    },
    {
      "@type": "Question",
      "name": "Can I give my dog oral or topical flea medicine with Bravecto Quantum?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Ask your veterinarian first. Do not combine another isoxazoline without specific veterinary direction."
      }
    },
    {
      "@type": "Question",
      "name": "What should I do if my dog misses the yearly injection?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Contact your veterinarian promptly. A late injection can create a gap in protection."
      }
    }
  ]
}
</script>

## Sources

1. [Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto Quantum™) against repeated infestations with Rhipicephalus sanguineus (sensu lato) and Ctenocephalides felis in dogs.](https://pubmed.ncbi.nlm.nih.gov/37872632/)
2. [Clinical efficacy and safety of a single administration of fluralaner injectable suspension (BRAVECTO® injectable) vs. monthly administration of oral afoxolaner (NexGard®) in dogs for tick and flea control over one year under European field conditions](https://pubmed.ncbi.nlm.nih.gov/39654069/)
3. [A single treatment with a fluralaner injectable suspension (Bravecto(®) injectable) provides 1-year efficacy against Rhipicephalus sanguineus sensu lato and Ctenocephalides felis in dogs.](https://pubmed.ncbi.nlm.nih.gov/39462404/)
4. [A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs.](https://pubmed.ncbi.nlm.nih.gov/24593931/)
5. [Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog.](https://pubmed.ncbi.nlm.nih.gov/31391054/)
6. [A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations](https://pubmed.ncbi.nlm.nih.gov/25129395/)
7. [A randomized, blinded, controlled USA field study to assess the use of fluralaner topical solution in controlling canine flea infestations](https://pubmed.ncbi.nlm.nih.gov/28103945/)
8. [A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto) treated vs. untreated dogs using the parameters tick weight and coxal index.](https://pubmed.ncbi.nlm.nih.gov/26123249/)
9. [Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto Quantum(TM)) against repeated infestations with Ixodes holocyclus in dogs.](https://pubmed.ncbi.nlm.nih.gov/37864235/)
10. [Topical or oral fluralaner efficacy against flea (Ctenocephalides felis) transmission of Dipylidium caninum infection to dogs.](https://pubmed.ncbi.nlm.nih.gov/30359284/)
11. [Survey of canine use and safety of isoxazoline parasiticides.](https://pubmed.ncbi.nlm.nih.gov/32485788/)
12. [Duration of annual canine flea and tick protection provided by dog owners in Spain](https://pubmed.ncbi.nlm.nih.gov/30086779/)
13. [Dog owner flea/tick medication purchases in the USA.](https://pubmed.ncbi.nlm.nih.gov/30400923/)
14. [Assessment of dog owner adherence to veterinarians' flea and tick prevention recommendations in the United States using a cross-sectional survey.](https://pubmed.ncbi.nlm.nih.gov/28583186/)
15. [Flea and tick treatment satisfaction, preference, and adherence of dog owners in the United States, United Kingdom, and Australia who treated their dog with fluralaner.](https://pubmed.ncbi.nlm.nih.gov/32821658/)